Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer

Molecular Differences between Ductal CarcinomaIn Situand Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study

(2015) Cathy B. Moelans et al.   Analytical Cellular Pathology

Comparison of Different Promoter Methylation Assays in Breast Cancer

(2015) Karijn P. M. Suijkerbuijk et al.   Analytical Cellular Pathology

Low Levels ofBNIP3Promoter Hypermethylation in Invasive Breast Cancer

(2015) Paul J. van Diest et al.   Analytical Cellular Pathology

Columnar Cell Lesions on Breast Needle Biopsies

(2011) Anoek H. J. Verschuur-Maes et al.   ANNALS OF SURGERY

Chromosomal Alterations in Pure Nonneoplastic Breast Lesions: Implications for Breast Cancer Progression

(2010) Rachel E. Ellsworth et al.   ANNALS OF SURGICAL ONCOLOGY

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

(2010) Weiwei Feng et al.   BMC CANCER

Methylation profiles of endometrioid and serous endometrial cancers

(2010) Laura M S Seeber et al.   ENDOCRINE-RELATED CANCER

Lack of RUNX3 inactivation in columnar cell lesions of breast

(2010) Manish Mani Subramaniam et al.   HISTOPATHOLOGY

Methylation profiles of hereditary and sporadic ovarian cancer

(2010) Guus M Bol et al.   HISTOPATHOLOGY

Simultaneous analysis of the methylation profile of 26 cancer related regions in invasive breast carcinomas by MS-MLPA and drMS-MLPA

(2010) Diego M. Marzese et al.   MOLECULAR AND CELLULAR PROBES

The epigenetics of breast cancer

(2010) Jovana Jovanovic et al.   Molecular Oncology

Promoter CpG island hypermethylation during breast cancer progression

(2010) So Yeon Park et al.   VIRCHOWS ARCHIV

Invasive Tubular Carcinoma of the Breast Frequently is Clonally Related to Flat Epithelial Atypia and Low-grade Ductal Carcinoma In Situ

(2009) Sebastian Aulmann et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

(2009) Liqiang Qi et al.   BMC CANCER

Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression

(2009) M. O. Hoque et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Methylation Profiles in Breast Cancer

(2009) Nur Buyru et al.   CANCER INVESTIGATION

Breast cancer precursors: lessons learned from molecular genetics

(2009) Hans-Peter Sinn   JOURNAL OF MOLECULAR MEDICINE-JMM

Differences and Molecular Immunohistochemical Parameters in the Subtypes of Infiltrating Ductal Breast Cancer

(2008) Cristina Bertolo et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer

(2008) K. P. M. Suijkerbuijk et al.   ANNALS OF ONCOLOGY

Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancer

(2008) Erik Noetzel et al.   BMC CANCER

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

(2008) H Suzuki et al.   BRITISH JOURNAL OF CANCER

Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category

(2008) E. I. Joensuu et al.   CANCER RESEARCH

Epigenetic inactivation of the secreted frizzled-related protein-5 ( SFRP5 ) gene in human breast cancer is associated with unfavorable prognosis

(2008) Jürgen Veeck et al.   CARCINOGENESIS

Methylation of CpG islands of p16INK4a and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast

(2008) Tieju Liu et al.   HUMAN PATHOLOGY